Hyperglycaemia after Capromorelin (Entyce) in cats

The FDA has received 52 reports of hyperglycaemia in cats after Capromorelin. That is 6.3% of all reports for this medicine, compared with 1.9% across reports for all cat medicines, so it is reported unusually often with this medicine.

52Reports

77%Marked serious

9.6%Recovered

31%Died or euthanised

3 daysTypical onset

How soon it started

Same day

16 33%

1–2 days

6 13%

3–7 days

9 19%

1–4 weeks

6 13%

Over a month

11 23%

How the animals did

Recovered

5 9.6%

Still unwell when reported

19 37%

Died

4 7.7%

Euthanised

12 23%

Not known

12 23%

Problems reported at the same time

23 44%

23 44%

21 40%

17 33%

16 31%

14 27%

14 27%

12 23%

Age of the animals

Under 1 year

1–3 years

4–7 years

8–11 years

12+ years

About this medicine

Capromorelin stimulates appetite.

Products with this ingredient include Entyce, Elura. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Capromorelin cause hyperglycaemia in cats?: 52 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?: In half of the reports with dates, it started within 3 days of the first dose.
What should I do?: Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Hyperglycaemia with similar medicines

Hyperglycaemia after Maropitant (Cerenia) 239 reports · 6.2% of its reports
Hyperglycaemia after Mirtazapine (Mirataz) 82 reports · 4.4% of its reports

All reported side effects of Capromorelin in cats · Medicines most reported with hyperglycaemia